David Wood, PhD

David Wood, PhD: Attorney with Borden Ladner Gervais LLP
  • Senior Associate at Borden Ladner Gervais LLP (913 Attorneys)
  • Centennial Place, East Tower, 1900, 520 - 3rd Avenue S.W., Calgary, AB, Canada M5H 3Y4
    View David Wood, PhD's office location
  • Peer Reviews
    No Reviews
    Client Reviews
    No Reviews
  • Profile Visibility [ i ]

Biography

Executive Summary

David Wood is a lawyer and patent agent in our Calgary office. David practices intellectual property and regulatory law. David is co-chair of the Borden Ladner Gervais Cannabis Industry Focus Group and his regulatory practice is specific to the Canadian cannabis industry.

David has advised licensed producers, pre-license entities, technology companies, and other domestic and foreign participants in the Canadian cannabis industry in relation to the Controlled Drugs and Substances Act and its regulations, including the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) and the Narcotic Control Regulations (the NCR ). David is also helping various industry participants position themselves for expected changes under Bill C-45: An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, Eliz. II: 64-65-66 (the Cannabis Act ).

David’s intellectual property practice and experience includes:
•drafting and prosecuting patent applications;
•assessing patentability of technology, validity of patents, and infringement of patents, and other patent-related due diligence;
•multi-jurisdictional patent portfolio management; and
•patent litigation.

David has experience with chemical, biochemical, information, and mechanical technologies relating to cannabis, medical devices, imaging, oil and gas, and other industries.

During his doctoral work, David characterized a complex between DNA and metal ions using a number of biochemical and biophysical techniques, including surface plasmon resonance spectroscopy, quenching of DNA-tethered fluorophores, and ethidium-based fluorescence assays. David’s education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian cannabis industry in relation to both intellectual property and regulatory law.

In addition to his technical background, David’s understanding of the ACMPR and other applicable law, his close attention to the Cannabis Act and Alberta's Bill 26: An Act to Control and Regulate Cannabis, and his familiarity with the Canadian cannabis industry and its participants, each add value when advising domestic and foreign clients in relation to developing or licensing technology related to the Canadian cannabis industry.

Publications & Presentations

•Author, A Tale of Two Cannabis Markets, BLG Publication, November 13, 2017.

•Panel Moderator, Canadian Cannabis Alberta Round Table and Networking Event , Glencoe Club, Calgary, November 9, 2017.

•Co-Author, Cannabis oil: Heavy on relief, light on cultural baggage, The Lawyer's Daily, July 21, 2017.

•Quoted, Cannabis and patents 101, Lift News, April, 2017.
•Co-Author, The Fall of the Green Wall: Legalizing Cannabis in Canada, BLG’s Securities and Capital Markets Bulletin, April 2017.
•Quoted, Legalization of marijuana could be boon for lawyers in many practice areas, The Lawyer's Daily, March, 2017.
•Author, ACMPR: Same as it Ever Was - with More Options for Patients and Licensed Producers, BLG's Securities & Capital Markets Bulletin, August 2016.
•Presenter, IP Agreements with Employers and Contractors - Common Pitfalls, BLG Employment Law Mini Symposium, May 11, 2016.
•Presenter, Protecting your Intellectual Capital in the Canadian Oil & Gas Industry, Canadian Energy Law Foundation Conference, Jasper, 2012.
•Contributing Author, Life Sciences and Chemical Patent Practice in Canada: A Practical Guide, 3rd Edition, BLG publication (complimentary copy available upon request), 2011.
•Wood, D.O. & Lee, J.S., Investigation of pH-dependent DNA-metal Ion Interactions by Surface Plasmon Resonance, Journal of Inorganic Biochemistry, 2005, 99: 566-574.
•S.D. Wettig, Wood, D.O., P. Aich, R.J.S. Skinner & J.S. Lee, Fluorescence Quenching in M-DNA: Formation and Electron Transfer Mechanisms, Journal of Inorganic Biochemistry, 2005, 99: 2093-2101.
•Wettig, S.D., Wood, D.O. & Lee, J.S., Thermodynamic Investigation of M-DNA: A Novel Metal Ion-DNA Complex, Journal of Inorganic Biochemistry, Bioch, 2003, 94: 94-99.
•Wood, D.O., Dinsmore, M.J., Bare, G.A. & Lee, J.S., M-DNA is Stabilized in G?C Tracts of by Incorporation of 5-fluorouracil, Nucleic Acids Research, 2002, 30: 2244-2250.

Areas of Practice (7)

  • Intellectual Property
  • Patents
  • Intellectual Property Litigation
  • Oil and Gas
  • Life Sciences
  • Healthcare Intellectual Property Protection and Commercialization
  • Cannabis

Education & Credentials

Contact Information:
403.232.9742  Phone
403.266.1395  Fax
www.blg.com
University Attended:
University of Saskatchewan, B.Sc., Biochemistry, 2000; University of Saskatchewan, Ph.D., Biochemistry, 2005
Law School Attended:
University of Saskatchewan, LL.B., 2008
Year of First admission:
2009
Admission:
2009, Alberta
Memberships:

Professional Involvement

•Affiliate member of the Intellectual Property Institute of Canada
•Member of the Canadian Bar Association
•Member of the Calgary Bar Association

Reported Cases:
Representative Work: Advising an international pharmaceutical company in relation the Access to Cannabis for Medical Purposes Regulations (the ACMPR ), cannabis supply, regulatory compliance and dosage forms.; Advising a national pharmacy chain in relation to cannabis supply, regulatory compliance and new product categories.; Advising a natural health products company in relation to the ACMPR, the Narcotic Control Regulations (the NCR ) and intellectual property.; Assisting with the going-public transaction for Brassneck Capital Corp. through reverse takeover by National Access Cannabis Corp.; Advising a food company in relation to the ACMPR, the NCR, and other aspects of positioning itself for sale of infused food products when solids containing cannabis are regulated for sale.; Advising multiple technology companies (domestic and foreign), including licensed producers, licensed dealers and applicants, in relation to: cannabis supply agreements; scope of activities under ACMPR licences, NCR licences, and Marihuana Medical Access Regulations licences extended by R v Allard; importation and exportation of cannabis under the ACMPR and the NCR; intellectual property licensing; patent rights, including drafting and filing patent applications in relation to biotechnology and dosage forms; plant breeder's rights and trade secrets; the scope of wares and services that may be included in trademark applications to position for adult use and for product diversity; Drafting website terms and conditions, and privacy policy, and advising in relation to advertising for a licensed producer and a social media company.; Advising an assisted living facility in relation to the scope of practice of nurses outside of hospitals, and in relation to a post-Cannabis Act adult use policy.; Working with professionals in BLG's corporate and immigration groups to move a skilled individual into Canada to work in the cannabis industry.
ISLN:
920745555
Payment Information:
  • Accepts
  • Peer Reviews

    This lawyer does not have peer reviews.

    *Peer Reviews provided before April 15, 2008 are not displayed.

    Client Reviews

    This attorney does not have client reviews.
    Disclaimer

    Documents ({{amountArticles}})

    Documents by this lawyer on Martindale.com
    Other documents: ,

    Calgary, Alberta

    • Calgary, AB
      Centennial Place, East Tower , 1900, 520 - 3rd Avenue S.W.
      Calgary, AB M5H 3Y4
       Canada

      403.232.9742 Phone

      Get Directions

    Contact David Wood, PhD

    Please correct the fields highlighted in red.

    By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.


    You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.